Mustang Bio Stock (NASDAQ: MBIO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 6.97K / 29.25M |
Day Range | - - - |
52 Wk Range | 0.13 - 5.48 |
Market Cap | $10.01M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 10.06% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mustang Bio (NASDAQ:MBIO) through any online brokerage.
Other companies in Mustang Bio’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN) and Lumos Pharma (NASDAQ:LUMO).
There is no analysis for Mustang Bio.
Mustang Bio has a consensus price target of $10.50.
The stock price for Mustang Bio (NASDAQ: MBIO) is $0.3104 last updated Today at July 22, 2024 at 4:24 AM EDT.
There are no upcoming dividends for Mustang Bio.
Mustang Bio’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Mustang Bio.
Mustang Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.